Skip to main content

Quick Connect

CPHI China 2024

Join us to discover how our API expertise can empower your business

June 19th - 21st, 2024
Shanghai New International Expo Center, China

Contact Us

Our Team at CPHI China 2024

About CPHI China 2024

CPHI & PMEC China is Asia's premier pharmaceutical event, bringing together suppliers and buyers across the entire pharmaceutical supply chain. Held in Shanghai at the Shanghai New International Expo Center, this in-person event unites the Chinese pharma community and fosters connections that drive innovation and industry growth.

Key highlights of CPHI China 2024:

  • Unrivalled networking opportunities: Connect with thousands of pharma professionals from across the globe.
  • Comprehensive exhibitor list: Discover a wide range of exhibitors across every sector of the Chinese pharmaceutical market.
  • Educational events: Gain insights from industry leaders through conferences and discussions.
  • Source cost-effective solutions: Find the latest advancements and solutions to optimise your business.

China 2024 is the ideal platform to expand business networks, discover new technologies, or find reliable partners.


About Dr.Reddy's API Business

We specialise in manufacturing and supplying a wide range of APIs for generic formulation manufacturers in India and overseas. The company has a diversified portfolio of 180+ active pharmaceutical ingredients, which are used in major therapeutic areas such as gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Our API manufacturing facilities adhere to cGMP (ICH Q7) and are inspected on a regular basis by international regulatory bodies. We have eight commercially inspected USFDA production plants, six in India and one each in Mexico and the United Kingdom

About Graph

About Graph

Dr. Reddy's API business operates in a number of global markets, including the United States of America, Latin America, Europe, India, Russia, and other CIS nations.



Dr. Reddy's is among the top sustainable pharmaceutical companies globally. We are listed in the sustainability yearbook of S&P 2022 for the second year in a row and the Bloomberg Gender-Equality Index (GEI) for the fifth consecutive year. In addition, we were ranked ninth in the Dow Jones Sustainability Index (DJSI) 2021 among the most sustainable pharmaceutical companies in the world. In our sustainability journey, these accolades are humbling and demonstrate that we're on the right track. These awards recognize our consistent performance in the environment, social, and governance (ESG) framework. Sustainability and ESG are becoming increasingly important topics for all stakeholders, so we will strive to maintain visibility in these areas.


Our Achievements

Our Plants

Dr. Reddy’s API  Manufacturing Locations


© 2024 Dr. Reddy’s Laboratories Ltd. All rights reserved.


No information in this catalog - including any reference to any product or service - constitutes an offer for sale, or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Products protected under valid patents in India are not available for commercial use but would be available for Section 107A purposes.